Construction and Expression of the Eukaryotic Coexpression Plasmid Containing PML-RARα245 and Hgm-Csf Gene

胡刚,周羽竝,岑东芝,杨力建,陈少华,李扬秋
DOI: https://doi.org/10.19460/j.cnki.0253-3685.2013.08.004
2013-01-01
Abstract:Objective To construct a eukaryotic coexpression plasmid containing PML-RARα245 gene and hGM-CSF gene using PML-RARα fusion gene segment with the length of 245 bp.MethodsPML-RARα fusion gene segment was amplified from NB4 cell line by RT-PCR and the whole hGM-CSF gene was amplified from pORF-hGM-CSF plasmid by PCR.Both PCR products were cloned into pIRES plasmid,respectively,to construct a recombinant plasmid pIRES-PML-RARα245-hGM-CSF.After being identified by double enzyme cutting and sequence analyzing,the recombinant plasmids were transfected into K562 cells.RT-PCR and dot blot techniques were used to detect the transcription and translation in eukaryotic cells.Results Restriction analysis(Nhe I/Mlu I,Xba I/Sal I) and sequence analysis confirmed that the length and the sequence of the fragments inserted into multi-clone site A and B of pIRES plasmid were absolutely correct.The transcription and translation of these recombinant plasmids in eukaryotic cells could be correctly detected.Conclusion A recombinant eukaryotic coexpression plasmid containing PML-RARα and hGM-CSF genes has been successfully constructed,which will provide more materials for the research of DNA vaccine used in the treatment of acute promyelocytic leukemia.
What problem does this paper attempt to address?